192 related articles for article (PubMed ID: 17250936)
1. A replication-competent adenovirus assay for E1-deleted Ad35 vectors produced in PER.C6 cells.
Marzio G; Kerkvliet E; Bogaards JA; Koelewijn S; De Groot A; Gijsbers L; Weverling GJ; Vogels R; Havenga M; Custers J; Pau MG; Guichoux JY; Lewis J; Goudsmit J
Vaccine; 2007 Mar; 25(12):2228-37. PubMed ID: 17250936
[TBL] [Abstract][Full Text] [Related]
2. A single short stretch of homology between adenoviral vector and packaging cell line can give rise to cytopathic effect-inducing, helper-dependent E1-positive particles.
Murakami P; Pungor E; Files J; Do L; van Rijnsoever R; Vogels R; Bout A; McCaman M
Hum Gene Ther; 2002 May; 13(8):909-20. PubMed ID: 12031124
[TBL] [Abstract][Full Text] [Related]
3. Human adenovirus type 35: nucleotide sequence and vector development.
Gao W; Robbins PD; Gambotto A
Gene Ther; 2003 Nov; 10(23):1941-9. PubMed ID: 14528318
[TBL] [Abstract][Full Text] [Related]
4. Degenerated pIX-IVa2 adenoviral vector sequences lowers reacquisition of the E1 genes during virus amplification in 293 cells.
Robert JJ; Gauffeny I; Maccario J; Jullien C; Benoit P; Vigne E; Crouzet J; Perricaudet M; Yeh P
Gene Ther; 2001 Nov; 8(22):1713-20. PubMed ID: 11892839
[TBL] [Abstract][Full Text] [Related]
5. Common structure of rare replication-deficient E1-positive particles in adenoviral vector batches.
Murakami P; Havenga M; Fawaz F; Vogels R; Marzio G; Pungor E; Files J; Do L; Goudsmit J; McCaman M
J Virol; 2004 Jun; 78(12):6200-8. PubMed ID: 15163713
[TBL] [Abstract][Full Text] [Related]
6. A Cre-expressing cell line and an E1/E2a double-deleted virus for preparation of helper-dependent adenovirus vector.
Zhou H; Zhao T; Pastore L; Nageh M; Zheng W; Rao XM; Beaudet AL
Mol Ther; 2001 Apr; 3(4):613-22. PubMed ID: 11319924
[TBL] [Abstract][Full Text] [Related]
7. Multiply deleted [E1, polymerase-, and pTP-] adenovirus vector persists despite deletion of the preterminal protein.
Hodges BL; Serra D; Hu H; Begy CA; Chamberlain JS; Amalfitano A
J Gene Med; 2000; 2(4):250-9. PubMed ID: 10953916
[TBL] [Abstract][Full Text] [Related]
8. A rapid and sensitive assay for detection of replication-competent adenoviruses by a combination of microcarrier cell culture and quantitative PCR.
Schalk JA; de Vries CG; Orzechowski TJ; Rots MG
J Virol Methods; 2007 Nov; 145(2):89-95. PubMed ID: 17588680
[TBL] [Abstract][Full Text] [Related]
9. A new vector system with inducible E2a cell line for production of higher titer and safer adenoviral vectors.
Zhou H; Beaudet AL
Virology; 2000 Sep; 275(2):348-57. PubMed ID: 10998335
[TBL] [Abstract][Full Text] [Related]
10. A novel system for the production of fully deleted adenovirus vectors that does not require helper adenovirus.
Cheshenko N; Krougliak N; Eisensmith RC; Krougliak VA
Gene Ther; 2001 Jun; 8(11):846-54. PubMed ID: 11423932
[TBL] [Abstract][Full Text] [Related]
11. Complementation of helper-dependent adenoviral vectors: size effects and titer fluctuations.
Alemany R; Dai Y; Lou YC; Sethi E; Prokopenko E; Josephs SF; Zhang WW
J Virol Methods; 1997 Nov; 68(2):147-59. PubMed ID: 9389404
[TBL] [Abstract][Full Text] [Related]
12. Improved glioblastoma treatment with Ad5/35 fiber chimeric conditionally replicating adenoviruses.
Hoffmann D; Meyer B; Wildner O
J Gene Med; 2007 Sep; 9(9):764-78. PubMed ID: 17640083
[TBL] [Abstract][Full Text] [Related]
13. Development of a recombinant adenovirus vector production system free of replication-competent adenovirus by utilizing a packaging size limit of the viral genome.
Suzuki T; Sasaki T; Yano K; Sakurai F; Kawabata K; Kondoh M; Hayakawa T; Yagi K; Mizuguchi H
Virus Res; 2011 Jun; 158(1-2):154-60. PubMed ID: 21470569
[TBL] [Abstract][Full Text] [Related]
14. New helper cells and matched early region 1-deleted adenovirus vectors prevent generation of replication-competent adenoviruses.
Fallaux FJ; Bout A; van der Velde I; van den Wollenberg DJ; Hehir KM; Keegan J; Auger C; Cramer SJ; van Ormondt H; van der Eb AJ; Valerio D; Hoeben RC
Hum Gene Ther; 1998 Sep; 9(13):1909-17. PubMed ID: 9741429
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of adenoviral vectors by flow cytometry.
Weaver LS; Kadan MJ
Methods; 2000 Jul; 21(3):297-312. PubMed ID: 10873484
[TBL] [Abstract][Full Text] [Related]
16. Development of a packaging cell line for propagation of replication-deficient adenovirus vector.
Kim JS; Lee SH; Cho YS; Park K; Kim YH; Lee JH
Exp Mol Med; 2001 Sep; 33(3):145-9. PubMed ID: 11642550
[TBL] [Abstract][Full Text] [Related]
17. [Quality control of clinical-grade recombinant adenovirus used in gene therapy].
Zhang XZ; Lin H; Yang XY; Wang CH; Zhang MM; Chen PL; Peng ZH
Zhonghua Yi Xue Za Zhi; 2004 May; 84(10):849-52. PubMed ID: 15200892
[TBL] [Abstract][Full Text] [Related]
18. Effects of the Ad5 upstream E1 region and gene products on heterologous promoters.
Hoffmann D; Jogler C; Wildner O
J Gene Med; 2005 Oct; 7(10):1356-66. PubMed ID: 15945123
[TBL] [Abstract][Full Text] [Related]
19. Isolation and characterization of packaging cell lines that coexpress the adenovirus E1, DNA polymerase, and preterminal proteins: implications for gene therapy.
Amalfitano A; Chamberlain JS
Gene Ther; 1997 Mar; 4(3):258-63. PubMed ID: 9135740
[TBL] [Abstract][Full Text] [Related]
20. Matching complementing functions of transformed cells with stable expression of selected viral genes for production of E1-deleted adenovirus vectors.
Howe JA; Pelka P; Antelman D; Wilson C; Cornell D; Hancock W; Ramachandra M; Avanzini J; Horn M; Wills K; Sutjipto S; Ralston R
Virology; 2006 Feb; 345(1):220-30. PubMed ID: 16246392
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
